EUCTR2011-005525-48-NO进行中（未招募）不适用
Potassium infusion for conversion of atrial fibrillation/atrial flutter.
Diakonhjemmet hospital0 个研究点开始时间: 2012年5月10日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Paroxysmal atrial fibrillation/ atrial flutter with duration < 48 hours.
- •- Serum-potassium = 4,0 mmol/l.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •- Kidney failure with eGFR <30ml/min
- •- Patients with ongoing treatment with anti arrhythmic drugs (flecainide, amiodarone, dronedarone or sotalol).
研究者
相似试验
已完成
4 期
Potassium Infusion for Conversion of Atrial Fibrillation/-FlutterAtrial FibrillationAtrial FlutterNCT01818583Diakonhjemmet Hospital143
已完成
不适用
Atrial specific potassium channels as new drug targets in atrial fibrillatioatrial fibrillation10007521NL-OMON29754niversiteit Maastricht50
尚未招募
1 期
FuLvning Decoction in the Treatment of Atrial Fibrillation Patient with Deficiency of Qi and Yin: a Randomized, Double-Blind Controlled TrialAtrial FibrillationITMCTR2000003694onghua Hospital, Shanghai University of Traditional Chinese Medicine
已完成
不适用
Treatment of paroxysmal atrial fibrillation with pill-in-the-pocket approach-comparison of propafenone and flecainideRecent-onset atrial fibrillationJPRN-UMIN000004553Fujita Health University School of Medicine50
尚未招募
不适用
CAtheter-Based Ablation of atrial fibrillation compared to conventional treatment in patients with Heart Failure with Preserved Ejection Fraction - Investigator-initiated, prospective, parallel-group, randomized, open, blinded endpoint assessment (PROBE), interventional multicenter strategy trialAtrial fibrillation and HFpEFheart failure with a preserved ejection fraction10007521NL-OMON56877Charité Universitätsmedizin Berlin150